Hook & Thesis
Everyone is bearish on lululemon right now: product fatigue, weaker North American apparel sales, and a fresh round of guidance cuts have driven the share price down to the low $90s. Headlines over the last few weeks have been uniformly negative, and short interest and short volume have jumped. That pessimism, combined with what we can see in the company's cash flow and valuation metrics, creates an attractive, tactical long opportunity.
In short: the worst of the downside looks largely priced in at today's levels. Lululemon trades at roughly 8x earnings with EV/EBITDA near 3.8x and price-to-sales just below 1x. The company still generates substantial free cash flow (about $1.35 billion), has a solid return on equity (roughly 29.6%) and an enterprise value under $10 billion against a market cap near $11.4 billion. A modest recovery in full-price sell-through, coupled with clearer execution on the product reset, should be enough to drive a mid-term multiple rerating. That asymmetric setup is the basis for this trade idea.
What lululemon Does and Why the Market Should Care
lululemon athletica designs and sells technical athletic apparel, footwear and accessories across company-operated stores and direct-to-consumer channels. The company sits at the premium end of the athleisure market: customers pay up for fit, fabrics and brand cachet. When core franchises run hot, lululemon can extract strong gross margins and meaningful operating leverage; when product loses momentum, the brand is more vulnerable than fast-fashion competitors because expectations — and pricing — are higher.
The market cares because lululemon is not a small niche brand anymore. It reported revenue in its latest quarter of roughly $2.4 billion (a 4% year-over-year decline per the most recent coverage) with comparable-store sales down about 9% — enough to shift sentiment quickly. Management's response is a focused product refresh, SKU rationalization and faster chase-volume replenishment. Those changes will take weeks to manifest in sell-through metrics but should help stabilize full-price sales if executed cleanly.
Numbers That Matter
- Current price: around $98 per share (recent trading).
- Market cap: roughly $11.36 billion.
- Enterprise value: ~$9.47 billion.
- Trailing earnings per share: ~$12.81; price-to-earnings around 7.7-8.0x.
- EV/EBITDA: ~3.76x; price-to-sales: ~0.98x; price-to-free-cash-flow: ~8.0x.
- Free cash flow: ~$1.35 billion; return on equity: ~29.6%.
- 52-week high: $225.98 (12/18/2025). 52-week low: $95.35 (09/17/2026).
Those multiples are inexpensive for a profitable, free-cash-flow-generating apparel brand with the scale and loyalty lululemon has. Even after recent guidance cuts (management expects a revenue decline and material EPS headwinds for fiscal 2026), the valuation reflects a large margin of safety.
Valuation Framing
Put simply: the market is valuing lululemon like a structurally impaired retailer rather than a high-margin, asset-light apparel business undergoing a cyclical reset. At an EV/EBITDA near 3.8x and P/E around 8x, investors are pricing a deep multi-year slowdown. If the company can halt comp deterioration and recover some full-price sell-through, even a modest rerating to P/E ~10-12x (still conservative relative to peak multiples) implies material upside from here.
Trade Plan (Actionable)
Thesis: Buy the dip to capture a multiple rerating as product and inventory actions restore full-price sales.
Trade direction: Long.
Time horizon: mid term (45 trading days). I expect the initial recovery signals (improving sell-through, fewer promotions and clearer product traction) to show up inside this window if the product refresh and chase replenishment work as intended.
- Entry price: $98.00
- Stop loss: $85.00
- Target price: $140.00
- Risk level: Medium
Rationale: Entry near $98 captures the recent sell-off and places the trade close to the 52-week low ($95.35). A stop at $85 limits downside to a level that would indicate a more material breakdown in demand or a fundamental shock beyond a tactical reset. The $140 target is achievable if EPS stabilizes and the market re-rates the stock to roughly 10-12x earnings (12.81 EPS x ~11 = ~$141). That represents a sensible mid-term rerating without requiring a full recovery to prior peaks.
Catalysts
- Product refresh early readouts - Management is reducing SKUs and pushing new away-from-body silhouettes and chase replenishment; better sell-through at full price would be an immediate positive (news item 09/18/2026 outlines this initiative).
- Sequential improvement in comparable-store sales - Any stabilization or improvement in North American comps would materially change sentiment.
- Margin stabilization - Inventory discipline and fewer promotions should support gross margin recovery; even modest margin improvement helps earnings leverage.
- Reduced headline risk - Resolution or containment of the current securities litigation noise and clearer messaging around guidance will reduce uncertainty and encourage risk-on positioning.
Risks and Counterarguments
- Execution risk on product reset: The pivot away from core leggings to looser silhouettes may not click with core customers. Early commentary already shows a 20% drop in traditional leggings sales; if new styles fail to scale, revenue could deteriorate further.
- Demand weakness persists: Broader consumer softness or intensified competition from brands like Alo Yoga and Vuori could keep comp sales under pressure and force continued markdowns.
- Guidance and earnings risk: Management has already cut full-year guidance materially (fiscal 2026 EPS expectations down sharply), and further negative revisions would likely push multiples lower.
- Legal and headline risk: The Pomerantz investigation stemming from the earnings release creates ongoing headline volatility and could distract management or result in settlement costs.
- Short-selling pressure: Short interest and recent short volume spikes increase the chance of volatile intra-day moves to the downside on negative headlines.
Counterargument: The bears are correct that lululemon faces a meaningful product-cycle reset and macro sensitivity. A durable change in consumer preferences away from premium athleisure would justify the low multiples. If comps continue to slide and margin restoration takes longer than management expects, the stock could fall well below current levels. That outcome keeps this trade higher risk and requires the stop to be respected.
What Would Change My Mind
I will abandon this long stance if any of the following occur: a) comparable-store sales show deeper deterioration on a sequential basis, b) management provides guidance implying a multi-year revenue decline rather than a one-year reset, or c) gross margin trends worsen materially due to required aggressive clearance activity. Conversely, sustained sequential improvement in full-price sell-through or clear signs that the new product franchises are resonating would reinforce this bullish view.
Bottom Line
The market has punished lululemon for a weak quarter, softer comps and necessary product changes. That punishment has pushed valuation to levels that make the risk/reward asymmetric for a tactical long — provided you size the position appropriately and use the stop. This is not a low-volatility trade; it is a disciplined, event-driven bet that execution on product, inventory discipline, and clearer guidance can restore full-price sales and prompt a multiple rerating. Entry around $98 with a $85 stop and a $140 target gives a clear plan with defined risk and a plausible path to upside within a mid-term 45 trading day window.